<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39175748</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2167-8359</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PeerJ</Title><ISOAbbreviation>PeerJ</ISOAbbreviation></Journal><ArticleTitle>Biological factors associated with long COVID and comparative analysis of SARS-CoV-2 spike protein variants: a retrospective study in Thailand.</ArticleTitle><Pagination><StartPage>e17898</StartPage><MedlinePgn>e17898</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e17898</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7717/peerj.17898</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Post-acute COVID-19 syndrome (long COVID) refers to the persistence of COVID-19 symptoms or exceptional symptoms following recovery. Even without conferring fatality, it represents a significant global public health burden. Despite many reports on long COVID, the prevalence and data on associated biological factors remain unclear and limited. This research aimed to determine the prevalence of long COVID during the two distinct epidemic periods in Thailand, due to the Delta and Omicron variants of SARS-CoV-2, and to investigate the biological factors associated with long COVID. In addition, the spike protein amino acid sequences of the Delta and Omicron variants were compared to determine the frequency of mutations and their potential biological implications.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A retrospective cross-sectional study was established to recruit confirmed COVID-19 participants at Maharat Nakhon Ratchasima Hospital who had recovered for at least three months and were infected between June 2021 and August 2022. The demographic data and long COVID experience were collected via telephone interview. The biological factors were analyzed through binary logistic regression. The datasets of the SARS-CoV-2 spike protein amino acid sequence of the Delta and Omicron variants in Thailand were retrieved from GIDSAID to determine mutation frequencies and to identify possible roles of the mutations based on published data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Data was collected from a total of 247 participants comprising 106 and 141 participants of the Delta and Omicron epidemic periods, respectively. Apart from the COVID-19 severity and health status, the baseline participant data of the two time periods were remarkably similar. The prevalence of long COVID observed in the Omicron period was higher than in the Delta period (74.5% <i>vs</i>. 66.0%). The biological factors associated with long COVID were epidemic variant, age, treatment with symptomatic medicines, and vaccination status. When the spike protein sequence data of the two variants were compared, it was observed that the Omicron variant exhibited a greater quantity of amino acid changes in its receptor-binding domain (RBD) and receptor-binding motif (RBM). The critical changes of the Omicron variant within these regions had a significant function in enhancing virus transmissibility and host immune response resistance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This study revealed informative data associated with long COVID in Thailand. More attention should be given to long COVID caused by unique virus variants and other biological factors to prepare a healthcare management strategy for COVID-19 patients after recovery.</AbstractText><CopyrightInformation>&#xa9;2024 Kiatratdasakul et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiatratdasakul</LastName><ForeName>Supanchita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Graduate Program in Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Rangsit Campus, Pathum Thani Province, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Maharat Nakhon Ratchasima Hospital, Mueang, Nakhon Ratchasima, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noisumdaeng</LastName><ForeName>Pirom</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Public Health, Thammasat University, Rangsit Campus, Pathum Thani Province, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Thammasat University Research Unit in Modern Microbiology and Public Health Genomics, Thammasat University, Rangsit Campus, Pathum Thani Province, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niyomdecha</LastName><ForeName>Nattamon</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Rangsit Campus, Pathum Thani Province, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PeerJ</MedlineTA><NlmUniqueID>101603425</NlmUniqueID><ISSNLinking>2167-8359</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="Y">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biological factors</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Spike protein</Keyword><Keyword MajorTopicYN="N">Thailand</Keyword></KeywordList><CoiStatement>The authors declare there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39175748</ArticleId><ArticleId IdType="pmc">PMC11340629</ArticleId><ArticleId IdType="doi">10.7717/peerj.17898</ArticleId><ArticleId IdType="pii">17898</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE. Central effects of ivermectin in alleviation of COVID-19-induced Dysauto-nomia. Current Drug Targets. 2022;23(13):1277&#x2013;1287. doi: 10.2174/1389450123666220810102406.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389450123666220810102406</ArticleId><ArticleId IdType="pubmed">35950254</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Thomali AW, Al-Kuraishy HM, Al-Gareeb AI, Al-Buhadiliy A, De&#xa0;Waard M, Sabatier JM, Khan&#xa0;Khalil AA, Saad HM, Batiha GE. Role of neuropilin 1 in COVID-19 patients with acute ischemic stroke. Biomedicines. 2022;10(8):2032. doi: 10.3390/biomedicines10082032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10082032</ArticleId><ArticleId IdType="pmc">PMC9405641</ArticleId><ArticleId IdType="pubmed">36009579</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with Delta versus Omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Welson NN. Pathophysiology of post-COVID syndromes: a new perspective. Virology Journal. 2022;19(1):158. doi: 10.1186/s12985-022-01891-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01891-2</ArticleId><ArticleId IdType="pmc">PMC9548310</ArticleId><ArticleId IdType="pubmed">36210445</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugatti A, Filippini F, Messali S, Giovanetti M, Ravelli C, Zani A, Ciccozzi M, Caruso A, Caccuri F. The D405N mutation in the spike protein of SARS-CoV-2 Omicron BA.5 inhibits spike/integrins interaction and viral infection of human lung microvascular endothelial cells. Viruses. 2023;15(2):332. doi: 10.3390/v15020332.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020332</ArticleId><ArticleId IdType="pmc">PMC9962894</ArticleId><ArticleId IdType="pubmed">36851546</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, Huang W, Li Q, Wang P, An R, Wang J, Wang Y, Niu X, Yang S, Liang H, Sun H, Li T, Yu Y, Cui Q, Liu S, Yang X, Du S, Zhang Z, Hao X, Shao F, Jin R, Wang X, Xiao J, Wang Y, Xie XS. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657&#x2013;663. doi: 10.1038/s41586-021-04385-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04385-3</ArticleId><ArticleId IdType="pmc">PMC8866119</ArticleId><ArticleId IdType="pubmed">35016194</ArticleId></ArticleIdList></Reference><Reference><Citation>Catala M, Mercade-Besora N, Kolde R, Trinh NTH, Roel E, Burn E, Rathod-Mistry T, Kostka K, Man WY, Delmestri A, Nordeng HME, Uuskula A, Duarte-Salles T, Prieto-Alhambra D, Jodicke AM. The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia. The Lancet Respiratory Medicine. 2024;S2213&#x2013;S2600(23):00414&#x2013;00419. doi: 10.1016/S2213-2600(23)00414-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00414-9</ArticleId><ArticleId IdType="pubmed">38219763</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg, Mohandas S, Bradfute SB, Recover Mechanistic Pathways Task&#xa0;Force Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang S, Ren L, Wang J. Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape. Chinese Medical Journal. 2022;135(10):1213&#x2013;1222. doi: 10.1097/CM9.0000000000002158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000002158</ArticleId><ArticleId IdType="pmc">PMC9337262</ArticleId><ArticleId IdType="pubmed">35788093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Disease Control of Thailand (DDC)  2024.  [28 January 2024]. https://ddc.moph.go.th/covid19-dashboard/</Citation></Reference><Reference><Citation>Department&#xa0;of Medical Science of Thailand&#xa0;(DMSc)  2023.  [18 January 2023]. https://ddc.moph.go.th/covid19-dashboard/</Citation></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2022;19(23):16010. doi: 10.3390/ijerph192316010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Elko EA, Mead HL, Nelson GA, Zaia JA, Ladner JT, Altin JA. Recurrent SARS-CoV-2 mutations at spike D796 evade antibodies from pre-omicron convalescent and vaccinated subjects. Microbiology Spectrum. 2024;12(2):e0329123. doi: 10.1128/spectrum.03291-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.03291-23</ArticleId><ArticleId IdType="pmc">PMC10871546</ArticleId><ArticleId IdType="pubmed">38189279</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatihi S, Rathore S, Pathak AK, Gahlot D, Mukerji M, Jatana N, Thukral L. A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features. Current Research in Structural Biology. 2021;3:290&#x2013;300. doi: 10.1016/j.crstbi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crstbi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8590475</ArticleId><ArticleId IdType="pubmed">34806033</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Sarkar S, Fram TR, Boppana S, Sterrett S, Qin K, Bansal A, Long DM, Sabbaj S, Kobie JJ, Goepfert PA, Erdmann N. Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses. JCI Insight. 2021;6(15):e151544. doi: 10.1172/jci.insight.151544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.151544</ArticleId><ArticleId IdType="pmc">PMC8410022</ArticleId><ArticleId IdType="pubmed">34143754</ArticleId></ArticleIdList></Reference><Reference><Citation>Focosi D, Novazzi F, Genoni A, Dentali F, Gasperina DD, Baj A, Maggi F. Emergence of SARS-COV-2 spike protein escape mutation Q493R after treatment for COVID-19. Emerging Infectious Diseases. 2021;27(10):2728&#x2013;2731. doi: 10.3201/eid2710.211538.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2710.211538</ArticleId><ArticleId IdType="pmc">PMC8462334</ArticleId><ArticleId IdType="pubmed">34314668</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, Bloom JD. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host &amp; Microbe. 2021;29(3):463&#x2013;476. doi: 10.1016/j.chom.2021.02.003e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.02.003e6</ArticleId><ArticleId IdType="pmc">PMC7869748</ArticleId><ArticleId IdType="pubmed">33592168</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, Ludden C, Reeve R, Rambaut A, COVID-19 Genomics UK (COG-UK)&#xa0;Consortium. Peacock SJ, Robertson DL. SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews. Microbiology. 2021;19(7):409&#x2013;424. doi: 10.1038/s41579-021-00573-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId><ArticleId IdType="pmc">PMC8167834</ArticleId><ArticleId IdType="pubmed">34075212</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A, Khan SA, Zia K, Altowyan MS, Barakat A, Ul-Haq Z. Deciphering the impact of mutations on the binding efficacy of SARS-CoV-2 omicron and delta variants with human ACE2 receptor. Frontiers in Chemistry. 2022;10:892093. doi: 10.3389/fchem.2022.892093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2022.892093</ArticleId><ArticleId IdType="pmc">PMC9213841</ArticleId><ArticleId IdType="pubmed">35755247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lista MJ, Winstone H, Wilson HD, Dyer A, Pickering S, Galao RP, De Lorenzo G, Cowton VM, Furnon W, Suarez N, Orton R. The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance. Journal of Virology. 2022;96(23):e0125022. doi: 10.1128/jvi.01250-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01250-22</ArticleId><ArticleId IdType="pmc">PMC9749455</ArticleId><ArticleId IdType="pubmed">36350154</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, Caminiti C. Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. Journal of Clinical Medicine. 2022;11(6):1541. doi: 10.3390/jcm11061541.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, Puhan MA. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PLOS ONE. 2021;16(7):e0254523. doi: 10.1371/journal.pone.0254523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254523</ArticleId><ArticleId IdType="pmc">PMC8274847</ArticleId><ArticleId IdType="pubmed">34252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E, Nelson AR, D&#x2019;Orazio LM, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Reiman EM, Caselli RJ, Chui HC, Tcw J, Chen Y, Pa J, Conti PS, Law M, Toga AW, Zlokovic BV. APOE4 leads to blood&#x2013;brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71&#x2013;76. doi: 10.1038/s41586-020-2247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2247-3</ArticleId><ArticleId IdType="pmc">PMC7250000</ArticleId><ArticleId IdType="pubmed">32376954</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, Gonz&#xe1;lez-delaAleja P, Boix V, Gil J, COVID19-ALC&#xa0;research group Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. Journal of Infection. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes&#xa0;of Health&#xa0;(NIH)  2022.  [15 June 2022]. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Niu Z, Zhang Z, Gao X, Du P, Lu J, Yan B, Wang C, Zheng Y, Huang H, Sun Q. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduction and Targeted Therapy. 2021;6(1):284. doi: 10.1038/s41392-021-00704-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00704-2</ArticleId><ArticleId IdType="pmc">PMC8313414</ArticleId><ArticleId IdType="pubmed">34315847</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, De Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, Pangilinan FC, Pastrana A, Goldrich N, Kavteladze D, Gellaco MML, Liu J, Lippi G, Henry BM, Fern&#xe1;ndez-de Las-Pe&#xf1;as C. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. Journal of Clinical Medicine. 2022;11(24):7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Office&#xa0;for National Statistics of the United Kingdom&#xa0;(ONS)  2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/3november2022/</Citation></Reference><Reference><Citation>Park SB, Khan M, Chiliveri SC, Hu X, Irvin P, Leek M, Grieshaber A, Hu Z, Jang ES, Bax A, Liang TJ. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype. Communications Biology. 2023;6(1):556. doi: 10.1038/s42003-023-04923-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04923-x</ArticleId><ArticleId IdType="pmc">PMC10206564</ArticleId><ArticleId IdType="pubmed">37225764</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastorio C, Zech F, Noettger S, Jung C, Jacob T, Sanderson T, Sparrer KMJ, kirchhoff F. determinants of spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2. Cell Host &amp; Microbe. 2022;30(9):1255&#x2013;1268. doi: 10.1016/j.chom.2022.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.07.006</ArticleId><ArticleId IdType="pmc">PMC9289044</ArticleId><ArticleId IdType="pubmed">35931073</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, Bontempo G, Marrella F, Tommasini A, Fabris M, Curcio F, Isola M, Tascini C. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clinical Microbiology and Infection. 2021;27(10):1507&#x2013;1513. doi: 10.1016/j.cmi.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M, Genotype&#xa0;to Phenotype Japan (G2P-Japan)&#xa0;Consortium. Tanaka S, Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602(7896):300&#x2013;306. doi: 10.1038/s41586-021-04266-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04266-9</ArticleId><ArticleId IdType="pmc">PMC8828475</ArticleId><ArticleId IdType="pubmed">34823256</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L, Ramezani M, Darazam IA, Sagharichi M, Aalipour MA, Ghorbani F, Pakdaman H. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. Journal of Neurovirology. 2021;27(1):154&#x2013;159. doi: 10.1007/s13365-021-00949-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00949-1</ArticleId><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Sharma K, Singh P, Bhargava A, Negi SS, Sharma P, Bhise M, Tripathi MK, Jindal A, Nagarkar NM. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India. Microbial Pathogenesis. 2022;164:105404. doi: 10.1016/j.micpath.2022.105404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2022.105404</ArticleId><ArticleId IdType="pmc">PMC8769534</ArticleId><ArticleId IdType="pubmed">35065253</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, Shah AD, Singh M, Kidy F, Okoth K, Hotham R, Bashir N, Cockburn N, Lee SI, Turner GM, Gkoutos GV, Aiyegbusi OL, McMullan C, Denniston AK, Sapey E, Lord JM, Wraith DC, Leggett E, Iles C, Marshall T, Price MJ, Marwaha S, Davies EH, Jackson LJ, Matthews KL, Camaradou J, Calvert M, Haroon S. Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine. 2022;28(8):1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Cardoso MJorge, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves CJ. Attributes and predictors of long COVID. Nature Medicine. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tancharoensukjit T. Prevalence and factors associated with post acute COVID syndrome (Long COVID) in patients infected coronavirus disease 2019 who received inpatient treatment Lan Krabue hospital. Journal of the Department of Medical Services. 2023;48(1):51&#x2013;59. (in Thai)</Citation></Reference><Reference><Citation>Theoharides TC. Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome? Molecular Neurobiology. 2022;59(3):1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Huggins CF, Kwong ASF, Silverwood RJ, Di Gessa G, Bowyer RCE, Northstone K, Hou B, Green MJ, Dodgeon B, Doores KJ, Duncan EL, Williams FMK, OpenSAFELY&#xa0;Collaborative. Steptoe A, Porteous DJ, McEachan RRC, Tomlinson L, Goldacre B, Patalay P, Ploubidis GB, Katikireddi SV, Tilling K, Rentsch CT, Timpson NJ, Chaturvedi N, Steves CJ. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications. 2022;13(1)::3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian D, Sun Y, Xu H, Ye Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. Journal of Medical Virology. 2022;94(6):2376&#x2013;2383. doi: 10.1002/jmv.27643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27643</ArticleId><ArticleId IdType="pmc">PMC9015498</ArticleId><ArticleId IdType="pubmed">35118687</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, O&#x2019;Connor L, Leavy D, O&#x2019;Brien K, Dowds J, Sugrue JA, Hopkins D, Martin-Loeches I, Cheallaigh CNi, Nadarajan P, McLaughlin AM, Bourke NM, Bergin C, O&#x2019;Farrelly C, Bannan C, Conlon N. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLOS ONE. 2020;15(11):e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Hu M, Liu B, Xu H, Jin Y, Wang B, Zhao Y, Wu J, Yue J, Ren H. Evaluating the effect of SARS-CoV-2 spike mutations with a linear doubly robust learner. Frontiers in Cellular and Infection Microbiology. 2023;13:1161445. doi: 10.3389/fcimb.2023.1161445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1161445</ArticleId><ArticleId IdType="pmc">PMC10154619</ArticleId><ArticleId IdType="pubmed">37153142</ArticleId></ArticleIdList></Reference><Reference><Citation>Wangchalabovorn M, Weerametachai S, Leesri T. Prevalence of post COVID-19 conditions in SARS-CoV-2 infected patients at 3-month telephone follow-up. Regional Health Promotion Center. 2022;9:265&#x2013;284. (in Thai)</Citation></Reference><Reference><Citation>Weir CB, Jan A. StatPearls. StatPearls Publishing; Treasure Island: 2023. [15 June 2022]. BMI classification percentile and cut off points.</Citation><ArticleIdList><ArticleId IdType="pubmed">31082114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm A, Toptan T, Pallas C, Wolf T, Goetsch U, Gottschalk R, Vehreschild MJGT, Ciesek S, Widera M. Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q. Viruses. 2021;13(9):1693. doi: 10.3390/v13091693.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091693</ArticleId><ArticleId IdType="pmc">PMC8473269</ArticleId><ArticleId IdType="pubmed">34578275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wongsermsin S, Chinoraso J, Yeekian C. Symptom and factors effect on severity of long COVID. Chonburi Hospital Journal. 2022;47(3):233&#x2013;240. (in Thai)</Citation></Reference><Reference><Citation>World Health Organization&#xa0;(WHO)   Clinical management of COVID-19 (Interim Guidance) World Health Organization; Geneva: 2020.  .&#xa0;https://iris.who.int/handle/10665/332196. 
</Citation></Reference><Reference><Citation>World Health Organization&#xa0;(WHO)   Post COVID-19 condition (Long COVID) World Health Organization; Geneva: 2022a.  .&#xa0;https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. 
</Citation></Reference><Reference><Citation>World Health Organization&#xa0;(WHO) Severity of disease associated with Omicron variant as compared with Delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection. World Health Organization; Geneva: 2022b.</Citation></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection. 2021;27(1):89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, Hsu F, Wenger NS. Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. Journal of General Internal Medicine. 2022;37(8):1988&#x2013;1995. doi: 10.1007/s11606-022-07523-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahradn&#xed;k J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J, Meyer B, Rudich Y, Li C, Marton I, Dym O, Elad N, Lewis MG, Andersen H, Gagne M, Seder RA, Douek DC, Schreiber G. SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nature Microbiology. 2021;6(9):1188&#x2013;1198. doi: 10.1038/s41564-021-00954-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00954-4</ArticleId><ArticleId IdType="pubmed">34400835</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>